NEW ORLEANS, Nov. 19, 2012 /PRNewswire/ -- PamLab L.L.C., developer and marketer of Metanx, announced today that a study published in The American Journal of Pharmacy Benefits demonstrates the effects ...
NEW ORLEANS--(BUSINESS WIRE)--Results from a study which evaluated Metanx ® on diabetic peripheral neuropathy using Zucker diabetic fatty (ZDF) rats, a model of Type 2 diabetes, were presented today ...
A large number of people in the New Orleans area have type 2 diabetes, a disease that affects nerves in the feet and legs. Diabetic neuropathy, which is nerve damage caused by high blood sugar levels, ...
PamLab announced that a study published in The American Journal of Pharmacy Benefits demonstrates the effects of Metanx (L-methylfolate, pyridoxal 5′-phosphate, methylcobalamin tablets) on ...
Paris—Oct. 27, 2009—Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results